MediFind
Condition

Multifocal Motor Neuropathy

Latest Research

Latest Advance
Study
  • Condition: Multifocal Motor Neuropathy
  • Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • Treatment Used: IVIg
  • Number of Patients: 11
  • Published —
This study tested the safety and efficacy of using IVIg to treat patients with multifocal motor neuropathy.
Latest Advance
Study
  • Condition: Multifocal Motor Neuropathy
  • Journal: Journal of neurology
  • Treatment Used: Human Immunoglobulin 10% with Recombinant Human Hyaluronidase
  • Number of Patients: 18
  • Published —
This study tested the safety and efficacy of using human immunoglobulin 10% alongside recombinant human hyaluronidase to treat patients with multifocal motor neuropathy.
Latest Advance
Study
  • Condition: Multifocal motor neuropathy
  • Journal: European journal of neurology
  • Treatment Used: Facilitated subcutaneous immunoglobulin
  • Number of Patients: 18
  • Published —
The study researched the safety and effectiveness of facilitated subcutaneous immunoglobulin for patients with multifocal motor neuropathy.
Latest Advance
Study
  • Condition: Multifocal Motor Neuropathy (MMN)
  • Journal: Journal of the peripheral nervous system : JPNS
  • Treatment Used: IqYmune® as Maintenance Therapy
  • Number of Patients: 22
  • Published —
This study evaluated the non-inferiority of IqYmune® relative to Kiovig®, primarily based on effectiveness criteria in the treatment of patients with multifocal motor neuropathy (MMN).
Latest Advance
Study
  • Condition: Autoimmune Diseases
  • Journal: Transfusion
  • Treatment Used: Rituximab
  • Number of Patients: 4584
  • Published —
This review of the literature determined the effectiveness and safety of rituximab in autoimmune diseases that are also treated with intravenous immunoglobulin (IVIG).
Latest Advance
Study
  • Condition: Autoimmune Neuropathies
  • Journal: Brain and behavior
  • Treatment Used: Home vs. Hospital Immunoglobulin Treatment
  • Number of Patients: 24
  • Published —
This study evaluated intravenous immunoglobulin (IVIg) administration (5% concentrated) at home versus in hospital with regard to costs, patients' autonomy, and patients' quality of life.
Latest Advance
Study
  • Condition: Chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropath
  • Journal: Muscle & nerve
  • Treatment Used: Intravenous to subcutaneous immunoglobulin
  • Number of Patients: 0
  • Published —
This study evaluated the variations in muscle strength and function in patients with chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropath by using intravenous (IVIg) to subcutaneous immunoglobulin (SCIg).